Posts Tagged ‘accelerator’
Neuronostics forms strategic partnership to deliver integrated EEG solutions for clinical trials
Neuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organizations (CROs) and academic partners. This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials…
Read MoreWilder Sensing secures investment to propel growth and innovation for biodiversity monitoring
Wilder Sensing, a developer of software for biodiversity monitoring using audio and Artificial Intelligence (AI), has secured £700,000 in equity investment. The South West Investment Fund awarded £300,000 via appointed Fund Manager The FSE Group, and additional funding was provided by Oxford Innovation Finance and Cambridge Angels. The new capital will enable the company…
Read MoreSETsquared event ignites opportunities for startup and spinout investment
In a vibrant display of entrepreneurial spirit, the SETsquared Partnership highlighted the investment potential of university startups and spinouts at a high-profile event in London last month. Investment Futures attracted a dynamic crowd of over 300 attendees, bringing together university researchers, innovators, industry experts and investors interested in capitalising on groundbreaking tech innovation. Our companies…
Read MoreAnna-Lisa Wesley: Founder folklore and fairytales – tech desperately needs new material
Anna-Lisa Wesley, Entrepreneur in Residence at SETsquared Bristol, reflects on the power of storytelling and needing new founder stories for our time. “Working in tech right now, we need some new heroes, heroines, new plots, new tools, new lessons. We desperately need new material.” Microsoft, Google, LinkedIn… these business stories, the founders that sit behind them and…
Read MoreLight Trace secures £600k to revolutionise photonic chip design
Light Trace Photonics, a leading innovator in the integrated photonics industry, has announced the close of its first investment round of £600,000. The company was co-founded by University of Bristol PhD researcher Dr Jake Biele who joined our incubation programme in May 2024 to commercialise and grow the company. This capital injection, led by QantX…
Read MoreWelcome to Rosie Bennett as our new Innovation Lead for Bristol Innovations
We are delighted to announce that Rosie Bennett joins the Bristol Innovations team as Innovation Lead. Rosie Bennett’s brief is across Bristol Innovations’ portfolio of incubators, innovation hubs and networks; SETsquared Bristol, Engine Shed, the Quantum Technologies Innovation Centre, Quantum Frontier, and the University of Bristol’s joint venture with Science Creates. As Innovation Lead, Rosie…
Read MoreKimberley Brook: Farewell – reflections from my time at SETsquared Bristol
After a wonderful few years working with SETsquared Bristol, my time at the tech incubator has come to an end as I move on to a new role as Head of Memberships for Capital Enterprise. I joined SETsquared Bristol in 2022 and became its Director in early 2023 with the aim to use my knowledge…
Read MoreDRIFT Energy plans first green hydrogen-producing vessel build following seed investment
DRIFT Energy has announced the close of its seed funding round led by Octopus Ventures, and with support from Blue Action Accelerator, the company has secured a total of £4.65 million seed investment. The climate tech startup joined our incubation programme in January 2023 with the goal to make green energy at sea using hi-tech…
Read MoreFluoretiQ patent granted to enable fast and accurate antibiotic testing
Bristol-based biotech company, FluoretiQ, who is developing fast and accurate point-of-care testing for Urinary Tract Infections (UTIs) and Sexually Transmitted Diseases (STDs), has taken a significant step forward after having a key patent granted. The University of Bristol spinout joined our incubation programme in 2021 with the vision of enabling more targeted antibiotic use and mitigating…
Read MoreGenomeKey awarded $11.4M to transform sepsis diagnosis and treatment
GenomeKey has been awarded a major grant from Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) to build a functioning, automated prototype of their desktop diagnostic device. The Bristol-based company joined our incubation programme in 2020 with a vision to build an in vitro diagnostic device that would completely transform the way we diagnose and treat sepsis…
Read More